A Randomized Open-Labeled Phase II Study of Combretastatin A-4 Phosphate in Combination With Paclitaxel and Carboplatin to Evaluate the Safety and Efficacy in Subjects With Advanced Imageable Malignancies

Trial Profile

A Randomized Open-Labeled Phase II Study of Combretastatin A-4 Phosphate in Combination With Paclitaxel and Carboplatin to Evaluate the Safety and Efficacy in Subjects With Advanced Imageable Malignancies

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Jul 2016

At a glance

  • Drugs Fosbretabulin (Primary) ; Carboplatin; Paclitaxel
  • Indications Solid tumours
  • Focus Therapeutic Use
  • Sponsors Mateon Therapeutics
  • Most Recent Events

    • 22 Aug 2011 Actual end date (February 2007) added as reported by ClinicalTrials.gov.
    • 22 Aug 2011 Actual initiation date (March 2005) added as reported by ClinicalTrials.gov.
    • 01 Jun 2007 Status changed to completed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top